The TRPV1 agonist capsaicin promotes prostate cancer cell death by phosphorylating LKB1 and activating AMPK, whereas siTRPV1 inhibits LKB1 and AMPK phosphorylation[35]. Here, TRPV1 is linked to prostate carcinoma.